1.
Clin Transl Sci
; 10(3): 143-146, 2017 05.
Article
in English
| MEDLINE
| ID: mdl-28294551
Subject(s)
Biomedical Research/organization & administration , Drug-Related Side Effects and Adverse Reactions/genetics , Evidence-Based Medicine/organization & administration , Interdisciplinary Communication , National Institutes of Health (U.S.)/organization & administration , Pharmacogenetics/organization & administration , Pharmacogenomic Variants/genetics , Animals , Biomedical Research/standards , Consensus , Cooperative Behavior , Drug-Related Side Effects and Adverse Reactions/diagnosis , Drug-Related Side Effects and Adverse Reactions/prevention & control , Evidence-Based Medicine/standards , Genotype , Humans , Pharmacogenetics/standards , Phenotype , Practice Guidelines as Topic , Risk Assessment , United States
2.
Clin Pharmacol Ther
; 99(6): 582-4, 2016 06.
Article
in English
| MEDLINE
| ID: mdl-26875057
ABSTRACT
Genetic and genomic discovery is revolutionizing medicine at an extraordinary pace, leading to a better understanding of disease and improved treatments for patients. This advanced pace of discovery presents an urgency to expand medical school curricula to include genetic and genomic testing (including pharmacogenomics), and integration of genomic medicine into clinical practice. Consequently, organizations and healthcare authorities have charged medical schools with training future physicians to be competent in their knowledge of genomic implementation.
